Weight gain following unilateral pallidotomy in Parkinson's disease

被引:45
作者
Ondo, WG
Ben-Aire, L
Jankovic, J
Lai, E
Contant, C
Grossman, R
机构
[1] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA
来源
ACTA NEUROLOGICA SCANDINAVICA | 2000年 / 101卷 / 02期
关键词
Parkinson's disease; pallidotomy; weight gain; stereotactic surgery; olfaction;
D O I
10.1034/j.1600-0404.2000.101002079.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - To determine the clinical correlates and infer pathogenesis of weight gain following pallidotomy in patients with Parkinson's disease (PD). Background - Surgical ablation of the globus pallidus internus (GPi) improves levodopa induced dyskinesias, moderately improves most other "cardinal" manifestations of PD, and has been noted to result in increased weight. Methods - We incorporated Unified Parkinson's Disease Rating Scales (UPDRS) subscales, the Beck depression inventory and feeding questionnaire data into a linear regression model in order to determine which post-surgical change(s) may lead to weight gain over the first year following pallidotomy, n = 60. Results - The mean weight gain 1 year after pallidotomy was 4.0 +/- 4.1 kg. Improvement in "off" motor scores (P < 0.005), especially gait subscores (P < 0.0001), and to a lesser extent improvement in "on" motor scores (P < 0.05) predicted weight gain. Changes in dyskinesia ratings, mood, food intake, dysphagia, levodopa dose, weight loss in the year prior to pallidotomy, age, and duration of PD did not correlate with subsequent weight gain. Conclusion - The high correlation between post-pallidotomy weight gain and "off" motor scores, suggests that this phenomenon is related to some change in underlying homeostasis associated with changes in the cardinal manifestations of PD itself, rather than secondary changes resultant from the surgery.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 38 条
[31]   Pallidotomy for generalized dystonia [J].
Ondo, WG ;
Desaloms, JM ;
Jankovic, J ;
Grossman, RG .
MOVEMENT DISORDERS, 1998, 13 (04) :693-698
[32]   THE ANTERIOR OLFACTORY NUCLEUS IN PARKINSONS-DISEASE [J].
PEARCE, RKB ;
HAWKES, CH ;
DANIEL, SE .
MOVEMENT DISORDERS, 1995, 10 (03) :283-287
[33]   Medical progress - Obesity [J].
Rosenbaum, M ;
Leibel, RL ;
Hirsch, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :396-407
[34]   OLFACTORY FUNCTION IN PARKINSONS-DISEASE SUBTYPES [J].
STERN, MB ;
DOTY, RL ;
DOTTI, M ;
CORCORAN, P ;
CRAWFORD, D ;
MCKEOWN, DA ;
ADLER, C ;
GOLLOMP, S ;
HURTIG, H .
NEUROLOGY, 1994, 44 (02) :266-268
[35]   A P-31 MAGNETIC-RESONANCE SPECTROSCOPY STUDY OF MITOCHONDRIAL-FUNCTION IN SKELETAL-MUSCLE OF PATIENTS WITH PARKINSONS-DISEASE [J].
TAYLOR, DJ ;
KRIGE, D ;
BARNES, PRJ ;
KEMP, GJ ;
CARROLL, MT ;
MANN, VM ;
COOPER, JM ;
MARSDEN, CD ;
SCHAPIRA, AHV .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 125 (01) :77-81
[36]   Free-living daily energy expenditure patients with Parkinson's disease [J].
Toth, MJ ;
Fishman, PS ;
Poehlman, ET .
NEUROLOGY, 1997, 48 (01) :88-91
[37]   Neuropathology of autonomic nervous system in Parkinson's disease [J].
Wakabayashi, K ;
Takahashi, H .
EUROPEAN NEUROLOGY, 1997, 38 :2-7
[38]   OLFACTORY FUNCTION IN ATYPICAL PARKINSONIAN SYNDROMES [J].
WENNING, GK ;
SHEPHARD, B ;
HAWKES, C ;
PETRUCKEVITCH, A ;
LEES, A ;
QUINN, N .
ACTA NEUROLOGICA SCANDINAVICA, 1995, 91 (04) :247-250